Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/1453206

Download in:

View as

General Info

PMID
1453206